12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

  • Second Sight Medical EYES shares rose 19.44% to $5.16 during Wednesday's after-market session. This security traded at a volume of 5.2 million shares come close, making up 98.14% of its average volume over the last 100 days. The company's market cap stands at $203.3 million.
  • Forward Pharma FWP stock moved upwards by 10.43% to $17.25. The company's market cap stands at $121.0 million.
  • Synaptogenix SNPX stock increased by 4.8% to $12.21. Today's trading volume for this security ended up closing at 82.8K shares, which is 14.35 percent of its average volume over the last 100 days. The company's market cap stands at $73.7 million.
  • Vyant Bio VYNT stock rose 4.7% to $3.34. The market value of their outstanding shares is at $96.8 million.
  • Aridis Pharmaceuticals ARDS stock rose 4.33% to $5.29. The company's market cap stands at $59.4 million.
  • Brickell Biotech BBI stock increased by 4.32% to $0.69. The market value of their outstanding shares is at $46.3 million.

Losers

  • TRACON Pharmaceuticals TCON shares fell 20.9% to $3.9 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 70.3K shares, which is 48.7 percent of its average volume over the last 100 days. The company's market cap stands at $60.4 million.
  • InspireMD NSPR shares decreased by 8.41% to $5.12. InspireMD's trading volume hit 190.5K shares by close, accounting for 27.14% of its average volume over the last 100 days. The company's market cap stands at $40.4 million.
  • Lexaria Bioscience LEXX shares declined by 7.23% to $7.83. At the close, Lexaria Bioscience's trading volume reached 215.8K shares. This is 22.95% of its average volume over the last 100 days. The market value of their outstanding shares is at $39.9 million.
  • Chembio Diagnostics CEMI shares fell 7.12% to $4.96. This security traded at a volume of 5.2 million shares come close, making up 1060.79% of its average volume over the last 100 days. The company's market cap stands at $100.4 million.
  • NeuroMetrix NURO stock fell 6.83% to $19.38. NeuroMetrix's trading volume hit 1.4 million shares by close, accounting for 32.32% of its average volume over the last 100 days. The company's market cap stands at $95.8 million.
  • Alterity Therapeutics ATHE stock declined by 4.23% to $1.36. The company's market cap stands at $54.5 million.

Posted In: BZI-TFMMovers

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.